T1	Disorder 8 23	Aplastic anemia
N1 	Reference T1 UMLS:C0002874	Aplastic anemia
T2	Disorder 28 43	agranulocytosis
N2 	Reference T2 UMLS:C0001824	agranulocytosis
T3	Pharmacological_substance 62 75	methazolamide
N1000 	Reference T3 MeSH:D008704	methazolamide
T4	Disorder 80 88	glaucoma
N3 	Reference T4 UMLS:C0017601	glaucoma
T5	Pharmacological_substance 91 120	Carbonic anhydrase inhibitors
N1001 	Reference T5 MeSH:D002257	Carbonic anhydrase inhibitors
T7	Disorder 146 154	glaucoma
N4 	Reference T7 UMLS:C0017601	glaucoma
T8	Disorder 156 173	seizure disorders
N5 	Reference T8 UMLS:C0014544	seizure disorders
T9	Disorder 179 191	hypertension
N6 	Reference T9 UMLS:C0020538	hypertension
T10	Disorder 219 235	blood dyscrasias
N7 	Reference T10 UMLS:C0018939	blood dyscrasias
T11	Disorder 261 276	aplastic anemia
N8 	Reference T11 UMLS:C0002874	aplastic anemia
T12	Pharmacological_substance 289 302	acetazolamide
N1002 	Reference T12 MeSH:D000086	acetazolamide
T13	Pharmacological_substance 330 343	methazolamide
N1003 	Reference T13 MeSH:D008704	methazolamide
T14	Disorder 414 429	aplastic anemia
N9 	Reference T14 UMLS:C0002874	aplastic anemia
T15	Pharmacological_substance 496 509	methazolamide
N1004 	Reference T15 MeSH:D008704	methazolamide
T16	Disorder 527 542	agranulocytosis
N10 	Reference T16 UMLS:C0001824	agranulocytosis
T17	Pharmacological_substance 565 578	methazolamide
N1005 	Reference T17 MeSH:D008704	methazolamide
T20	Speculation_cue 457 473	almost certainly
